Intellectual Property India Publishes Patent Application for 'Ai-Guided Pipeline For Repurposing Fda-Approved Drugs Using Multi-Omics Graph Neural Networks And Mechanism-Constrained Screening' Filed by IIMT College of Pharmacy

MUMBAI, India, Feb. 6 -- Intellectual Property India has published a patent application (202511131764 A) filed by IIMT College of Pharmacy, Greater Noida, Uttar Pradesh, on Dec. 25, 2025, for 'ai-guided pipeline for repurposing fda-approved drugs using multi-omics graph neural networks and mechanism-constrained screening.'

Inventor(s) include Nakul Gupta; Ravi Rawat; Shweta Sharma; and Sudhir Arora.

The application for the patent was published on Feb. 6, under issue no. 06/2026.

According to the abstract released by the Intellectual Property India: "The invention provides a computer-implemented system (100) and method for repurposing approved drugs using a mechanism-constrained multi-omics platform. The system (100) includes a data inges...